Availability and quality of data on pharmaceutical benefit financing components of health care system in United States, United Kingdom, Denmark, Germany, Italy and Poland

Authors

  • Tomasz Hermanowski
  • Sylwia I. Szafraniec-Burylo
  • Urszula Cegłowska
  • Aleksandra Drozdowska
  • Dominika Duleba
  • Marta Kowalczyk
  • Aleksandra N. Krancberg
  • Chris L. Pashos
  • Andrzej Szczypior
  • Malgorzata Chmielewska
  • Marcin Czech

DOI:

https://doi.org/10.5334/ijic.1280

Keywords:

pharmaceutical benefit, United Kingdom, Denmark, Germany, Italy, Poland

Author Biographies

Tomasz Hermanowski

PhD, Professor, Head of Department of Pharmacoeconomics; InterQuality Project Leader, Medical University of Warsaw, Poland

Sylwia I. Szafraniec-Burylo

MD, PhD, Department -Centre for Monitoring and Analyses of Population Health Status and Health Care System, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland

Urszula Cegłowska

MSc, Medical University of Warsaw, Poland

Aleksandra Drozdowska

MSc, Medical University of Warsaw, Poland

Dominika Duleba

MSc, Medical University of Warsaw, Poland

Marta Kowalczyk

MSc, Medical University of Warsaw, Poland

Aleksandra N. Krancberg

MSc, Medical University of Warsaw, Poland

Chris L. Pashos

PhD, United BioSource Corporation, Lexington, MA, USA

Andrzej Szczypior

MSc, Sopharm, Warsaw, Poland

Malgorzata Chmielewska

MSc, Medical University of Warsaw, Poland

Marcin Czech

MD, PhD, Associate Professor, Department of Pharmacoeconomics, Medical University of Warsaw, Poland

Downloads

Published

2013-10-23

Issue

Section

Poster Abstracts